Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors.

Sansone A, Lauretta R, Vottari S, Chiefari A, Barnabei A, Romanelli F, Appetecchia M.

Cancers (Basel). 2019 Aug 4;11(8). pii: E1113. doi: 10.3390/cancers11081113. Review.

2.

Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study.

Trimboli P, Palermo A, Deandrea M, Piccardo A, Campennì A, Valabrega S, Grani G, Santolamazza G, Bottoni G, Barnabei A, Ramundo V, Lauretta R, Monte L, Ferrarazzo G, Paone G, Crosetto C, Ruggeri RM, Baldari S, Chiefari A, Vottari S, Giarnieri E, Perrella E, Limone P, Durante C, Giovanella L, Appetecchia M, Crescenzi A.

Endocrine. 2019 Jul 16. doi: 10.1007/s12020-019-02013-9. [Epub ahead of print]

PMID:
31313225
3.

Endocrine Disrupting Chemicals: Effects on Endocrine Glands.

Lauretta R, Sansone A, Sansone M, Romanelli F, Appetecchia M.

Front Endocrinol (Lausanne). 2019 Mar 21;10:178. doi: 10.3389/fendo.2019.00178. eCollection 2019. Review.

4.

Ultrasound-guided laser ablation for local control of neck recurrences of medullary thyroid cancer. A feasibility study.

Persichetti A, Bizzarri G, Guglielmi R, Barnabei A, Bianchini A, Coccaro C, Appetecchia M, Papini E.

Int J Hyperthermia. 2018;35(1):480-492. doi: 10.1080/02656736.2018.1508759. Epub 2018 Sep 11.

PMID:
30204004
5.

Chromogranin A as a biomarker for prostate cancer: is it actually relevant for clinical practice?

Appetecchia M, Lauretta R, Sperduti I, Gallucci M.

Future Oncol. 2018 Jun;14(13):1233-1235. doi: 10.2217/fon-2018-0025. Epub 2018 May 1. No abstract available.

6.

Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.

Trimboli P, Lauretta R, Barnabei A, Valabrega S, Romanelli F, Giovanella L, Appetecchia M.

Int J Biol Markers. 2018 May;33(2):156-160. doi: 10.1177/1724600817747518. Epub 2018 Apr 30.

PMID:
29707993
7.

Indirect Basal Metabolism Estimation in Tailoring Recombinant Human TSH Administration in Patients Affected by Differentiated Thyroid Cancer: A Hypothesis-Generating Study.

Barnabei A, Strigari L, Persichetti A, Baldelli R, Rizza L, Annoscia C, Lauretta R, Cigliana G, Barba M, De Leo A, Appetecchia M, Torino F.

Front Endocrinol (Lausanne). 2018 Feb 15;9:37. doi: 10.3389/fendo.2018.00037. eCollection 2018.

8.

Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer.

Sponziello M, Benvenuti S, Gentile A, Pecce V, Rosignolo F, Virzì AR, Milan M, Comoglio PM, Londin E, Fortina P, Barnabei A, Appetecchia M, Marandino F, Russo D, Filetti S, Durante C, Verrienti A.

Hum Mutat. 2018 Mar;39(3):371-377. doi: 10.1002/humu.23378. Epub 2017 Dec 20.

PMID:
29219214
9.

Erratum to: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.

Prodosmo A, Buffone A, Mattioni M, Barnabei A, Persichetti A, De Leo A, Appetecchia M, Nicolussi A, Coppa A, Sciacchitano S, Giordano C, Pinnarò P, Sanguineti G, Strigari L, Alessandrini G, Facciolo F, Cosimelli M, Grazi GL, Corrado G, Vizza E, Giannini G, Soddu S.

J Exp Clin Cancer Res. 2016 Nov 28;35(1):185. No abstract available.

10.

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk.

Lauretta R, Lanzolla G, Vici P, Mariani L, Moretti C, Appetecchia M.

Int J Endocrinol. 2016;2016:8671762. Epub 2016 Sep 20. Review.

11.

Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.

Prodosmo A, Buffone A, Mattioni M, Barnabei A, Persichetti A, De Leo A, Appetecchia M, Nicolussi A, Coppa A, Sciacchitano S, Giordano C, Pinnarò P, Sanguineti G, Strigari L, Alessandrini G, Facciolo F, Cosimelli M, Grazi GL, Corrado G, Vizza E, Giannini G, Soddu S.

J Exp Clin Cancer Res. 2016 Sep 6;35(1):135. doi: 10.1186/s13046-016-0410-3. Erratum in: J Exp Clin Cancer Res. 2016 Nov 28;35(1):185.

12.

Early diagnosis by FNA cytology should not influence the outcome of differentiated thyroid cancer.

Trimboli P, Nigri G, Guidobaldi L, Romanelli F, Aurello P, Crescenzi A, Appetecchia M, Giovanella L, Valabrega S.

Endocr J. 2016 Apr 25;63(4):367-73. doi: 10.1507/endocrj.EJ15-0634. Epub 2016 Jan 27.

13.

Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement.

Garberoglio R, Aliberti C, Appetecchia M, Attard M, Boccuzzi G, Boraso F, Borretta G, Caruso G, Deandrea M, Freddi M, Gallone G, Gandini G, Gasparri G, Gazzera C, Ghigo E, Grosso M, Limone P, Maccario M, Mansi L, Mormile A, Nasi PG, Orlandi F, Pacchioni D, Pacella CM, Palestini N, Papini E, Pelizzo MR, Piotto A, Rago T, Riganti F, Rosato L, Rossetto R, Scarmozzino A, Spiezia S, Testori O, Valcavi R, Veltri A, Vitti P, Zingrillo M.

J Ultrasound. 2015 Jun 19;18(4):423-30. doi: 10.1007/s40477-015-0169-y. eCollection 2015 Dec. No abstract available.

14.

Real-world study of everolimus in advanced progressive neuroendocrine tumors.

Panzuto F, Rinzivillo M, Fazio N, de Braud F, Luppi G, Zatelli MC, Lugli F, Tomassetti P, Riccardi F, Nuzzo C, Brizzi MP, Faggiano A, Zaniboni A, Nobili E, Pastorelli D, Cascinu S, Merlano M, Chiara S, Antonuzzo L, Funaioli C, Spada F, Pusceddu S, Fontana A, Ambrosio MR, Cassano A, Campana D, Cartenì G, Appetecchia M, Berruti A, Colao A, Falconi M, Delle Fave G.

Oncologist. 2015 May;20(5):570. doi: 10.1634/theoncologist.2014-0037erratum. No abstract available.

15.

Ultrasound features of medullary thyroid carcinoma correlate with cancer aggressiveness: a retrospective multicenter study.

Trimboli P, Giovanella L, Valabrega S, Andrioli M, Baldelli R, Cremonini N, Rossi F, Guidobaldi L, Barnabei A, Rota F, Paoloni A, Rizza L, Fattorini G, Latini M, Ventura C, Falasca P, Orlandi F, Crescenzi A, D'Ambrosio F, Cantisani V, Romanelli F, Negro R, Saggiorato E, Appetecchia M.

J Exp Clin Cancer Res. 2014 Oct 25;33:87. doi: 10.1186/s13046-014-0087-4.

16.

Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature.

Appetecchia M, Barnabei A, Pompeo V, Sentinelli S, Baldelli R, Corsello SM, Torino F.

BMC Endocr Disord. 2014 Oct 11;14:84. doi: 10.1186/1472-6823-14-84. Review.

17.

Real-world study of everolimus in advanced progressive neuroendocrine tumors.

Panzuto F, Rinzivillo M, Fazio N, de Braud F, Luppi G, Zatelli MC, Lugli F, Tomassetti P, Riccardi F, Nuzzo C, Brizzi MP, Faggiano A, Zaniboni A, Nobili E, Pastorelli D, Cascinu S, Merlano M, Chiara S, Antonuzzo L, Funaioli C, Spada F, Pusceddu S, Fontana A, Ambrosio MR, Cassano A, Campana D, Cartenì G, Appetecchia M, Berruti A, Colao A, Falconi M, Delle Fave G.

Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12. Erratum in: Oncologist. 2015 May;20(5):570.

18.

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes.

Bianchi A, Valentini F, Iuorio R, Poggi M, Baldelli R, Passeri M, Giampietro A, Tartaglione L, Chiloiro S, Appetecchia M, Gargiulo P, Fabbri A, Toscano V, Pontecorvi A, De Marinis L.

J Exp Clin Cancer Res. 2013 Jun 21;32:40. doi: 10.1186/1756-9966-32-40.

19.

Thyroid dysfunction as an unintended side effect of anticancer drugs.

Torino F, Barnabei A, Paragliola R, Baldelli R, Appetecchia M, Corsello SM.

Thyroid. 2013 Nov;23(11):1345-66. doi: 10.1089/thy.2013.0241. Epub 2013 Sep 21. Review.

PMID:
23750887
20.

New perspectives on diagnostics, prognosis, and therapy in aggressive endocrine tumours.

Appetecchia M, Wolffenbuttel BH, Al Jadir S.

J Oncol. 2012;2012:820938. doi: 10.1155/2012/820938. Epub 2012 Dec 5. No abstract available.

Supplemental Content

Loading ...
Support Center